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Abstract
The effectiveness of vaccine mixtures against lactococcosis was tested in rainbow trout
(Oncorhynchus mykiss). The M1 strain of Lactococcus garvieae, isolated from a recent outbreak
of lactococcosis at a rainbow trout farm in Turkey, was used in a trial comparing five immuniza-
tion treatments: (a) formalin inactivated bacterin (vaccine), (b) the above bacterin together with
Freund’s Incomplete Adjuvant (FIA), (c) the bacterin combined with β-glucan, (d) β-glucan only,
and (e) phosphate buffered saline-PBS (control). Fish were given intrapritoneal injections and
challenged by exposure to the bacteria 30, 75, or 125 days after vaccination. In fish exposed to
the bacteria 30 days after injection, the relative percent survival (RPS) was 88.89% in the group
that received only bacterin and 100% in the group that received the bacterin combined with FIA.
Immunity remained high in the bacterin+FIA group, as the RPS in this group remained 100% in
fish challenged at 75 days, significantly higher than in all other groups. In fish exposed to the
bacteria 125 days after vaccination, the RPS was 54.55% in fish vaccinated with the bacterin
only and 84.84% in fish vaccinated with bacterin+FIA. In the group that received only β-glucan,
immunity did not improve after vaccination. Micro-agglutination tests of serums showed that
immunized fish produced antibodies at high titers within 30 days. In short, the formalin-inacti-
vated M1 strain provided longer lasting protection against Lactococcus garvieae in rainbow trout
when combined with FIA than when administered alone or with β-glucan.
Introduction
Lactococcosis is a worldwide septicemic fish
disease characterized by bilateral exoph-
thalmia and caused by the bacteria
Lactococcus garvieae (Austin and Austin
1999; Kusuda and Salati, 1999). A variety of
fish species can be affected by this disease
(Eldar and Ghittino, 1999; Diler et al., 2002;
Salati et al., 2005). Lactococcosis infection is
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the single most important risk factor in the
European trout industry, with losses approxi-
mating 50% of the total annual production
(Eyngor et al., 2004). The impact of lactococ-
cosis is particularly significant as losses often
occur when fish reach market size (Ceschia et
al., 1998).
In Turkey, L. garvieae was first isolated in
2001 after an outbreak on rainbow trout farms
(Diler et al., 2002; Altun et al., 2004). Since
then, infections have been repeatedly occur-
ring, especially during the warm summer
months. Lactococcus  garvieae is now consid-
ered one of the most important pathogens in
Turkey’s rainbow trout industry. 
Lactococcus garvieae is a gram-positive
coccus. It is oxydase and catalase negative,
non-motile, and a facultatively anaerobic bac-
teria. Antimicrobials have not been successful
against L. garvieae as resistance is rapidly
developed. Thus, the only possible means of
control is vaccination (Romalde et al., 2004;
Salati et al., 2005 ). 
Among the commercially available bac-
terins against bacterial fish pathogens, none
exist for L. garvieae (Romalde et al., 2004).
Production of lactococcosis vaccines have
been attempted (Bercovier et al., 1997), also
with the use of other gram-positive pathogens
(Eldar et al., 1997; Romalde et al., 1999).
However, the short duration of immunity (two
or three months) limits the success of these
vaccines since the immunity does not persist
throughout the entire warm season when the
majority of lactococcosis outbreaks occur
(Bercovier et al., 1997; Romalde et al., 2004;
Ravelo et al., 2006). 
The aim of this study was to test the effi-
cacy and lasting level of a formalin-killed vac-
cine alone and together with immunostimu-
lants against lactococcosis in rainbow trout.
Materials and Methods
Fish. Juvenile rainbow trout were obtained
from a farm with no history of lactococcosis
and acclimated for six weeks. The fish were
fed commercial pellets at 2% body weight per
day.
Selection of the bacterial strain. The vac-
cine was prepared from the M1 strain of L.
garvieae isolated during a natural outbreak
that occurred in a rainbow trout farm in
Fethiye-Mugla, Turkey (Diler et al., 2002).
This strain was selected among several
strains on the basis of antigenic characteris-
tics determined in earlier studies (Altun et al.,
2004, 2007). The reference strain NCDO
2155 (ATCC-43921) was compared with the
isolated strain after inoculation on trypticase
soy agar (TSA, Difco Laboratories, Detroit,
MI) and incubation at 25°C for 24-48 h. Pure
bacteria were transferred to tryptic soy broth
(Difco Laboratories, Detroit, MI) and pure cul-
ture stocks were stored at -80°C in tryptic soy
broth (TSB, Difco) containing 15% glycerol.
Immunostimulant and adjuvant. Freund’s
Incomplete Adjuvant (FIA; Sigma Chemical
Co., St Louis, MO, cat. no. F-5506) and β-glu-
can (Sigma, cat. no. G-6513) were used as
immunostimulants.
Enhancing the virulency of the M1 strain.
In vivo passage was used to increase the vir-
ulency of the L. garvieae M1 strain (Eldar et
al., 1995). The LD50 of the M1 strain was cal-
culated by determining the cumulative mortal-
ity rates one month after injection of M1 strain
at two doses. 
Preparation of the bacterin. A formalin-
killed bacterin was prepared from the selected
strain according to Eldar et al. (1997). The
strain was grown in TSB for 24 h and the bac-
terial cells were inactivated by adding formalin
until a final concentration of 0.7% was
obtained. The solution was incubated at 25°C
for 3 h and then overnight at 4°C. Thereafter,
the inactivated bacterial cells were washed
three times with phosphate buffered saline
(PBS) by centrifugation at 6000 x g for 30 min
at 4°C. The formalin-killed vaccine was resus-
pended in PBS and adjusted by optical densi-
ty to a final concentration of about 1 x 1011
CFU/ml (OD600 of 1.2) 
Immunization. Six hundred fish (avg wt 20
g) were divided into ten groups and two
groups were injected intraperitonally (i.p.) with
each of the following five treatments: (a) 0.1
ml bacterin at a concentration of 1 x 1010
CFU/ ml, (b) the same amount of bacterin plus
Freund’s Incomplete Adjuvant (FIA) at a ratio
of 1:1, (c) the same amount of bacterin plus β-
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glucan, (d) β-glucan alone at 2 mg/fish, or (e)
phosphate buffered saline (control). Fish were
anesthetized using quinaldine (1/20,000) prior
to injection. Fifty fish in each group were chal-
lenged as specified below to determine rela-
tive percent survival and 10 were examined in
a micro-agglutination assay to determine anti-
body titers.
Fish were kept in 600-l tanks with an open
flow of fresh water at 1-1.5 l/min and constant
aeration. Water temperature was kept at
12°C. After vaccination fish were fed commer-
cial pellets (extruded feed no. 3, 45% protein,
20% lipids, Kilic Feed, Mugla, Turkey) at 2%
body weight per day.
Challenge tests and determination of vac-
cine potency. Fish were challenged 30, 75,
and 125 days after immunization with a
homologous strain of L. garvieae prepared as
above and individually injected at 0.1 ml/fish.
Mortality was recorded daily for three weeks
after challenge. Internal organs of all dead fish
were examined to confirm infection by re-iso-
lating the inoculated strain. The efficacy of the
vaccine in each trial was assessed by calcu-
lating the relative percent survival (RPS;
Amend, 1981) using the formula: RPS = 1 -
(% mortality in vaccinated fish/% mortality in
control) x 100. 
Serum samples. At 30, 75, and 125 days
post-vaccination, ten fish from each group
(twenty from each treatment) were briefly
anesthetized and bled by dorsal aorta punc-
ture to collect serum for determination of anti-
body titer. Blood samples were centrifuged at
3000 rpm for 10 min. The serum was collect-
ed and aliquots of the serum were kept at
-20°C until required for assay.
Micro-agglutination tests. Serial two-fold
dilutions of the serum samples in PBS were
added to round-bottom polystrene, 96-well,
microplates in triplicate for the microagglutina-
tion tests. Each reaction contained 100 µl of
the M1 strain of L. garvieae at a concentration
of 1.2 x 109 CFU/ml. The bacterium was inac-
tivated with formalin. The microplates were
shaken and incubated at 37°C for 2 h and left
overnight at 4°C. The appearance of a button
with fuzzy edges at the bottom of the well was
considered a positive reaction, the formation
of a round precipitate with sharp contours was
considered a negative reaction (Eldar et al.,
1997; Barnes et al., 2002). 
Statistical analysis. Results were analyzed
by ANOVA and significances were detected
by Duncan test (SPSS 9.0 package for
Windows).
Results 
The bacteria produced 50% cumulative mor-
tality at a concentration of 4.69 x 107 CFU/ml.
Protection levels (resistance or strength of
the immunological response) after injection
are given in Table 1. Vaccines containing bac-
terin resulted in greater levels of protection
than the control, indicated by the lower mor-
tality and higher RPS in fish exposed 30 days
after vaccination. Protection remained high
over time as significant differences in mortali-
ty were observed between the control and the
treatment groups even when fish were
exposed to the bacteria 75 and 125 days after
vaccination. The statistically highest level of
protection was achieved in rainbow trout that
received the bacterin+FIA vaccine. In addi-
tion, no side effects were observed other than
internal organ adhesion. Fish inoculated with
β-glucan alone did not benefit from improved
protective immunity.
Serum agglutinating antibody titers are
given in Table 2. Independent of the vaccina-
tion regime, the average antibody titers
against formalin-killed antigens of the M1
strain of L. garvieae employed in the vaccine
formulation were 1/512 within 30 days after
immunization. In addition, an increase in cir-
culating specific antibodies was observed in
fish vaccinated with bacterin plus FIA or β-glu-
can. Therefore, the humoral response corre-
lated with the degree of protection conferred
by the vaccine.
Discussion
Good protection levels are achieved only
when vaccines are intraperitoneally adminis-
tered (Bercovier et al., 1997). Immersion pro-
cedures produce a lesser degree of protection
against gram-positive bacterial infections in
salmonids (Bercovier et al., 1997; Romalde et
al., 2004). In our study, RPS was 88.89%
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when trout were exposed to L. garvieae 30
days after i.p. administration of the prepared
bacterin only, similar to other results of i.p.
immunization of fish, e.g., 90.0% RPS against
Streptococcus iniae (Eldar et al., 1997),
83.3% RPS against L. garvieae (Romalde et
al., 2004), and 82.6% RPS against L.
garvieae (Ravelo et al., 2006). These results
indicate a good initial level of protection but a
very short duration of immunity (approximate-
ly 3 months; Bercovier et al., 1997). Likewise
in our study, the initial level of protection was
relatively good (88.89% RPS) but dropped to
54.55% RPS after 125 days (post-vaccina-
tion).
Romalde et al. (2004) studied the efficacy
of oral immunization using alginate-micropar-
ticles for a booster vaccination in rainbow
trout to prevent lactococcosis. In fish that
received an initial i.p. vaccination with aque-
ous bacterin and an oral alginate-encapsulat-
ed booster vaccine 90 days later, protection
reached 87% RPS 30 days after revaccina-
tion. 
Another approach to increasing vaccine
potency and/or duration of protection, without
revaccination, is to use adjuvants in the vac-
cine formulation (Anderson, 1997). Ravelo et
al. (2006) investigated the use of adjuvanted
vaccines to lengthen protection against lacto-
coccosis in rainbow trout. Oil preparations
have been used with a high degree of success
to prevent a number of bacterial fish diseases
(Anderson, 1992; Newman, 1993; Rahman et
al., 2000). The use of oil-based adjuvants has
now been successfully combined with
injectable bacterins in fish. The oil-adjuvants
generate a ‘depot effect’, causing the antigen
to be slowly released into the tissue or blood,
enhancing and prolonging the humoral
response (Anderson, 1997). In the present
study, we evaluated the addition of an adju-
vant to the vaccine formulation. A significantly
higher level of protection (100% RPS) was ini-
tially obtained (on days 30 and 75) in fish
immunized with bacterin+FIA and the duration
of the immulogical protection was extended,
reaching an RPS of 84.84% 125 days after
immunization.
A number of studies examined the role of
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glucans as immunostimulants during immune
system challenge, in particular, their role in
non-specific defense against disease. In our
study, we examined the effect of β-glucan on
the activation of the specific and non-specific
immune system. Although β-glucan has been
shown to enhance non-specific defense
mechanisms, this stimulation did not correlate
with improved protection in rainbow trout
infected with L. garvieae in our study as the
percent mortality in fish vaccinated with β-glu-
can did not differ than in the unvaccinated
control. Toranzo et al. (1995) obtained similar
results in turbot infected with Enterecoccus
sp.
In conclusion, our results suggest that pro-
tection against L. garvieae in rainbow trout is
attained up to 125 days when the bacterin is
formulated from inactivated whole cells and
combined with FIA, but not β-glucan, and
administered intraperitoneally. Our test vac-
cines were prepared in multiple batches and
results were consistent regardless of the
batch used to immunize the test fish. These
results will help in developing an appropriate
immunization program to prevent lactococco-
sis outbreaks in rainbow trout aquaculture
operations. Fish farms with a short production
cycle (less than 6 months) could benefit from
this adjuvanted vaccine.
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